1. Home
  2. Analysis
  3. Elidel
  4. Zelnorm

Elidel and Zelnorm drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Elidel and Zelnorm. Common interactions include abdominal pain among females.

The phase IV clinical study analyzes what interactions people who take Elidel and Zelnorm have. It is created by eHealthMe based on reports of 8 people who take Elidel and Zelnorm from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Nov, 30, 2022

8 people who take Elidel and Zelnorm together, and have interactions are studied.

What is Elidel?

Elidel has active ingredients of pimecrolimus. It is often used in eczema. eHealthMe is studying from 4,405 Elidel users for its effectiveness, alternative drugs and more.

What is Zelnorm?

Zelnorm has active ingredients of tegaserod maleate. eHealthMe is studying from 7,217 Zelnorm users for its effectiveness, alternative drugs and more.

Number of Elidel and Zelnorm reports submitted per year:

Elidel and Zelnorm drug interactions.

Common Elidel and Zelnorm drug interactions by gender *:

female:

  1. Abdominal pain
  2. Cerebrovascular accident
  3. Hypertension
  4. Non-cardiac chest pain
  5. Rectal haemorrhage
  6. Abdominal abscess
  7. Abdominal adhesions
  8. Abdominal pain lower
  9. Abdominal tenderness
  10. Back pain

male:

n/a

Common Elidel and Zelnorm drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Abdominal abscess
  2. Abdominal adhesions
  3. Abdominal pain lower
  4. Abdominal tenderness
  5. Colitis ischaemic
  6. Colostomy
  7. Cushingoid
  8. Diarrhoea haemorrhagic
  9. Drug ineffective
  10. Flushing

30-39:

n/a

40-49:

  1. Abdominal pain
  2. Cerebrovascular accident
  3. Cerebrovascular disorder
  4. Chest pain
  5. Diabetes mellitus
  6. Diabetic neuropathy
  7. Fibromyalgia
  8. Gastrointestinal pain
  9. Hypertension
  10. Non-cardiac chest pain

50-59:

n/a

60+:

  1. Back pain
  2. Blood pressure increased
  3. Insomnia
  4. Joint effusion
  5. Malaise
  6. Medical device complication
  7. Medical device pain
  8. Muscle strain
  9. Nausea
  10. Oedema peripheral

* Approximation only. Some reports may have incomplete information.

Do you take Elidel and Zelnorm?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Elidel and Zelnorm:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Elidel side effects:

Browse all side effects of Elidel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Zelnorm side effects:

Browse all side effects of Zelnorm:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Elidel interactions:

Browse all interactions between Elidel and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Zelnorm interactions:

Browse all interactions between Zelnorm and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on pimecrolimus and tegaserod maleate (the active ingredients of Elidel and Zelnorm, respectively), and Elidel and Zelnorm (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Elidel and Zelnorm.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.